Relay Therapeutics to Participate in Upcoming Investor Conferences
May 21 2024 - 4:05PM
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision
medicine company transforming the drug discovery process by
combining leading-edge computational and experimental technologies,
today announced that management will participate in two upcoming
fireside chats:
- TD Cowen 5th Annual Oncology Innovation Summit, taking place
virtually on Tuesday, May 28, 2024 at 9:30 a.m. ET
- Goldman Sachs 45th Annual Global Healthcare Conference on
Wednesday, June 12, 2024 at 8:40 a.m. ET
The fireside chats will be webcast live and may be accessed
through Relay Therapeutics’ website under Events in the News &
Events section through the following link:
https://ir.relaytx.com/news-events/events-presentations. An
archived replay of the webcast will be available for up to 30 days
following the event.
About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine
company transforming the drug discovery process by combining
leading-edge computational and experimental technologies with the
goal of bringing life-changing therapies to patients. As the first
of a new breed of biotech created at the intersection of
complementary techniques and technologies, Relay Therapeutics aims
to push the boundaries of what’s possible in drug discovery. Its
Dynamo™ platform integrates an array of leading-edge computational
and experimental approaches designed to drug protein targets that
have previously been intractable or inadequately addressed. Relay
Therapeutics’ initial focus is on enhancing small molecule
therapeutic discovery in targeted oncology and genetic disease
indications. For more information, please visit www.relaytx.com or
follow us on Twitter.
Contact:Megan Goulart617-545-5526
mgoulart@relaytx.com
Media:Dan
Budwick1AB973-271-6085dan@1abmedia.com
Relay Therapeutics (NASDAQ:RLAY)
Historical Stock Chart
From May 2024 to Jun 2024
Relay Therapeutics (NASDAQ:RLAY)
Historical Stock Chart
From Jun 2023 to Jun 2024